233 results on '"Swain, Erik"'
Search Results
2. Change for the better: machining and laser processing suppliers are constantly adapting their offerings and changing the way they do business in order to meet heightened expectations from medical device OEMs
3. Design and technology evolve together: radical new medical device designs have prompted radical new machining and laser processing technologies
4. A seamless transition: prototyping and production are now integrated to the point of being separate stages of the same discipline. Here is how medical device OEMs can leverage those trends
5. The many challenges of extrusion: matching product needs to supplier capabilities and anticipating variables is key to successfully navigating this difficult discipline
6. Faster, finer, cleaner: medical device OEMs in need of complex, detailed parts manufactured quickly, precisely, and accurately, increasingly are turning to laser-based processes
7. Early planning, future reward: proper product development involves taking proactive steps to avoid pitfalls that may come when potential risks are not adequately considered
8. Software opens new frontier of quality: device companies must have the right software in place to prevent issues with quality
9. Tubing designs bring extrusion challenges: medical tubing designs are getting more complex, which has led some companies to rethink their extrusion processes
10. Choosing materials wisely: as orthopedic designs change rapidly, so must orthopedic materials. Close collaboration between OEMs and suppliers is the best way to keep pace
11. It all adds up: additive manufacturing is bringing drastic change for the better to the orthopedic prototyping process
12. Collaboration early, success later: there are many benefits to seeking input from your materials suppliers early in the product development process
13. Lean for low volumes: in today's manufacturing and business climates, there is no excuse for orthopedic companies to avoid implementing Lean principles or a similar program
14. Early and often: a good orthopedic prototyping process results from early collaboration and constant feedback between OEMs and suppliers
15. More than scratching the surface: orthopedic device coating and surface modification processes have become more automated, improving the consistency, quality and safety of devices
16. Choosing a coating: the right surface modification technique brings benefits to patients with implants
17. Instruments evolve to fit orthopedic surgeons' needs
18. Fda Clears Next-Generation Cardiovascular, Thoracic Ct Scanners.
19. The New Casual Friday
20. Trial of vitamin D supplementation raises questions about CV effects on older adults.
21. POET: Oral antibiotics viable residual treatment for left-sided endocarditis.
22. Oral PCSK9 inhibitor lowers LDL similar to injection in short-term phase 2 trial.
23. Hospital readmissions present a complex, costly issue for US cardiologists.
24. New technological advances propel the field of arrhythmia disorders.
25. PAD widely prevalent, consequences could be dire.
26. CVD prevention, treatment challenging as patients with HIV, HCV live longer.
27. Meta-analysis questions strength of ties between statin-induced LDL lowering, CV outcomes.
28. Adults with congenital heart disease present challenges, rewards for cardiologists.
29. Choosing Materials Wisely.
30. A Seamless Transition.
31. A Good Diagnosis.
32. Faster, Finer, Cleaner.
33. Early and Often.
34. Transradial approach to PCI, diagnostic angiography brings favorable costs, improved quality of life.
35. Groundbreaking clinical results for CoreValve may transform treatment of aortic stenosis.
36. A call for increased awareness of the high stroke burden in women.
37. FDA panel votes against recommending approval of serelaxin.
38. Experts consider CV implications of SGLT2 inhibitors.
39. New guideline eases target BP thresholds in adults.
40. Future unclear for platelet function and genetic testing for patients with ACS, stents.
41. Despite headlines, role of statins in cancer prevention far from proven.
42. Many drug therapy options exist for NAFLD.
43. Managing dyslipidemia in pregnant women challenging.
44. Tools of Change.
45. Rarely or Never Consuming Breakfast Increases Risk for Stroke.
46. REDUCE-IT: Icosapent ethyl reduces ischemic events in high-risk patients.
47. Cholesterol guideline updated with newer medications, more personalized risk calculation.
48. ASCEND: Aspirin, omega-3 supplements fail for primary prevention in diabetes.
49. Minor infections may increase children's risk for stroke.
50. FDA panel discusses potential utility of fixed-combination drugs in US.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.